Brett C. Sheppard

7.7k total citations · 1 hit paper
186 papers, 5.1k citations indexed

About

Brett C. Sheppard is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Brett C. Sheppard has authored 186 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Surgery, 74 papers in Oncology and 63 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Brett C. Sheppard's work include Pancreatic and Hepatic Oncology Research (56 papers), Esophageal and GI Pathology (26 papers) and Gallbladder and Bile Duct Disorders (26 papers). Brett C. Sheppard is often cited by papers focused on Pancreatic and Hepatic Oncology Research (56 papers), Esophageal and GI Pathology (26 papers) and Gallbladder and Bile Duct Disorders (26 papers). Brett C. Sheppard collaborates with scholars based in United States, Saudi Arabia and United Kingdom. Brett C. Sheppard's co-authors include Clifford W. Deveney, John G. Hunter, James P. Dolan, Blair A. Jobe, Brian S. Diggs, Lee L. Swanström, Jeffrey A. Norton, Carlos A. Pellegrini, Lee M. Mitsumori and Brant K. Oelschlager and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Brett C. Sheppard

180 papers receiving 4.9k citations

Hit Papers

Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk D... 2015 2026 2018 2022 2015 100 200 300

Peers

Brett C. Sheppard
Brett C. Sheppard
Citations per year, relative to Brett C. Sheppard Brett C. Sheppard (= 1×) peers Yoshiaki Iwasaki

Countries citing papers authored by Brett C. Sheppard

Since Specialization
Citations

This map shows the geographic impact of Brett C. Sheppard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett C. Sheppard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett C. Sheppard more than expected).

Fields of papers citing papers by Brett C. Sheppard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett C. Sheppard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett C. Sheppard. The network helps show where Brett C. Sheppard may publish in the future.

Co-authorship network of co-authors of Brett C. Sheppard

This figure shows the co-authorship network connecting the top 25 collaborators of Brett C. Sheppard. A scholar is included among the top collaborators of Brett C. Sheppard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett C. Sheppard. Brett C. Sheppard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Seung-Won, Mark Berry, Jason M. Link, et al.. (2025). Protocol to purify and culture human pancreatic cancer cells from patient-derived xenografts. STAR Protocols. 6(1). 103672–103672.
2.
Mira, Jose L., Jessica Minnier, Benjamin R. Kingston, et al.. (2025). Early detection of pancreatic cancer by a high-throughput protease-activated nanosensor assay. Science Translational Medicine. 17(785). eadq3110–eadq3110. 14 indexed citations
3.
Caspi, Caitlin E., et al.. (2024). Experiences with COVID-19 economic relief measures among low-wage worker families: a qualitative study. BMC Public Health. 24(1). 3330–3330.
4.
Parappilly, Michael, Emile Latour, Lei Wang, et al.. (2024). Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Cancer. Cancers. 16(21). 3650–3650.
5.
Shah, Vidhi M., Syed Rizvi, Alexander Smith, et al.. (2023). Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor Microenvironment. Pharmaceutics. 15(12). 2651–2651. 5 indexed citations
6.
Sutton, Thomas L., et al.. (2023). Care at high‐volume centers is associated with improved outcomes for patients with pancreatic neuroendocrine tumors: A population‐level analysis. Journal of Surgical Oncology. 127(6). 956–965. 1 indexed citations
7.
Lopez, Charles D., Adel Kardosh, Shaun M. Goodyear, et al.. (2023). Casper: A phase I, open-label, dose finding study of calaspargase pegol-mnkl (cala) in combination with cobimetinib (cobi) in locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC).. Journal of Clinical Oncology. 41(4_suppl). TPS772–TPS772. 2 indexed citations
8.
Shah, Vidhi M., Craig Dorrell, Adel Al Fatease, et al.. (2022). Microfluidics Formulated Liposomes of Hypoxia Activated Prodrug for Treatment of Pancreatic Cancer. Pharmaceutics. 14(4). 713–713. 15 indexed citations
9.
Sutton, Thomas L., David L. Warner, Gregory L. Moneta, et al.. (2022). Patency for autologous vein is superior to cadaveric vein in portal-mesenteric venous reconstruction. HPB. 24(8). 1326–1334. 1 indexed citations
10.
Allen-Petersen, Brittany L., Tyler Risom, Zipei Feng, et al.. (2018). Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma. Cancer Research. 79(1). 209–219. 62 indexed citations
11.
Dolan, James P., Brian S. Diggs, Paul H. Schipper, et al.. (2017). Evolution in the Treatment of Esophageal Disease at a Single Academic Institution: 2004–2013. Journal of Laparoendoscopic & Advanced Surgical Techniques. 27(9). 915–923. 7 indexed citations
12.
Wang, Zhiping, Dexi Chen, Zhiyi Zhu, et al.. (2016). ΔN-ASPP2, a novel isoform of the ASPP2 tumor suppressor, promotes cellular survival. Biochemical and Biophysical Research Communications. 482(4). 1271–1277. 10 indexed citations
13.
Gunderson, Andrew J., Megan M. Kaneda, Takahiro Tsujikawa, et al.. (2015). Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancer. Cancer Discovery. 6(3). 270–285. 381 indexed citations breakdown →
14.
Mitchell, Erica L., Mark Jones, Gregory J. Landry, et al.. (2010). Techniques and results of portal vein/superior mesenteric vein reconstruction using femoral and saphenous vein during pancreaticoduodenectomy. Journal of Vascular Surgery. 51(3). 662–666. 50 indexed citations
15.
Perry, Kyle A., et al.. (2009). Laparoscopic adrenalectomy for large unilateral pheochromocytoma: experience in a large academic medical center. Surgical Endoscopy. 24(6). 1462–1467. 18 indexed citations
16.
Enestvedt, C. Kristian, Skye C. Mayo, Brian S. Diggs, et al.. (2008). Diagnostic Laparoscopy for Patients with Potentially Resectable Pancreatic Adenocarcinoma: Is It Cost-Effective in the Current Era?. Journal of Gastrointestinal Surgery. 12(7). 1177–1184. 25 indexed citations
17.
Dolan, James P., et al.. (2005). Retained Common Bile Duct Stone as a Consequence of a Fundus-First Laparoscopic Cholecystectomy. Journal of Laparoendoscopic & Advanced Surgical Techniques. 15(3). 318–321. 3 indexed citations
18.
Fennerty, M. Brian, Christopher L. Corless, Brett C. Sheppard, et al.. (2001). Pathological documentation of complete elimination of Barrett's metaplasia following endoscopic multipolar electrocoagulation therapy. Gut. 49(1). 142–144. 15 indexed citations
19.
Calogero, Aldo E., Jeffrey A. Norton, Brett C. Sheppard, et al.. (1992). Pulsatile activation of the hypothalamic-pituitary-adrenal axis during major surgery. Metabolism. 41(8). 839–845. 44 indexed citations
20.
Rao, Vidhya R., et al.. (1980). Further evidence for cyclic-AMP mediation of the stimulatory effect of dopamine on renin release in vitro. Federation Proceedings. 39. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026